(PharmaNewsWire.Com, March 03, 2021 ) This report aims to provide detailed insights into the global vascular patches market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.
Key Factors Driving Market Growth:
Growth in the Vascular Patches Market is mainly driven by the rapidly growing geriatric population and the subsequent increase in the prevalence of vascular diseases, the increasing number of vascular surgeries performed, and the increasing adoption of biological patches. The emerging markets are expected to offer a wide range of growth opportunities for players in the market.
On the other hand, product failures and recalls are expected to limit market growth in the coming years. The need for highly skilled professionals may also challenge market growth to a certain extent.
Expected Revenue Growth:
The vascular patches market is expected to reach USD 525.8 Million by 2023 from USD 349.6 Million in 2018, at a CAGR of 8.5%.
Browse 65 market data Tables and 31 Figures spread through 100 Pages and in-depth TOC on "Vascular Patches Market".
The biologic vascular patch segment accounted for the largest share of the market in 2017
Based on material, the Vascular Patches Market is segmented into biologic vascular patches and synthetic vascular patches. Of all these product segments, biologic vascular patches accounted for the largest share of the market in 2017. The large share of this market segment can primarily be attributed to the wide range of advantages associated with the use of biologic vascular patches such as superior biocompatibility, ease of use, minimal suture line bleeding, and reduced rates of infection in comparison with synthetic patches.
The hospitals & clinics segment is estimated to grow at the highest CAGR during the forecast period.
Based on end user, the Vascular Patches Market has been segmented into hospitals & clinics and ambulatory surgical centers. The hospitals & clinics segment is estimated to grow at the highest CAGR during the forecast period. The growth of this end-user segment is majorly attributed to factors such as the growth in the number of vascular procedures in hospitals and improving healthcare infrastructure in several developing countries across the globe.
North America commanded the largest share of the market in 2017.
Based on region, the Vascular Patches Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2017, North America accounted for the largest share of the Vascular Patches Industry. The growing prevalence of vascular diseases and the rising geriatric population in this region as well as the presence of all the major players in this region are the major factors supporting the growth of the Vascular Patches Industry in North America.
The major players in the Vascular Patches Market include Terumo Corporation (Japan), C. R. Bard, Inc. (US), B. Braun Melsungen AG (Germany), LeMaitre Vascular, Inc. (US), Maquet (Germany), W. L. Gore & Associates, Inc. (US), Admedus (Australia), CryoLife, Inc. (US), Labcor Laboratórios Ltda (Brazil), Baxter International Inc. (US), and Edwards Lifesciences Corporation (US).
Given the immense opportunities in the major applications of vascular patches products, market leaders, and emerging players are increasingly focusing on the market segments mentioned above to increase their revenues and are also looking to expand their reach to emerging economies.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
